Trial Profile
A Pilot Study on the Combined Use of Cognitive Behavioral Therapy (CBT) and Milnacipran.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 12 Nov 2012 Primary endpoint 'Pain-intensity' has not been met.
- 12 Nov 2012 Primary endpoint 'Medical-Outcome-Study-Short-Form-36' has not been met.